Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
D003692:Delayed-Action Preparations; D005475:Flupenthixol / Q000627:therapeutic use*; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy*; D013892:Thioxanthenes / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D013892:Thioxanthenes; D005475:Flupenthixol; D005476:Fluphenazine